Teva Recalls Propranolol 10 mg Tablets Due to Weight Issues
Teva Pharmaceuticals is recalling specific lots of Propranolol Hydrochloride 10 mg tablets because some may not meet weight specifications.
Recall notice
Failed Tablet/Capsule Specification: Teva is recalling certain lots of Propanolol HCl Tablets, 10 mg due to the potential of some tablets not conforming to weight specification.
Contact the company
What happened, in plain English
Teva Pharmaceuticals USA, Inc. has recalled certain lots of Propranolol Hydrochloride Tablets, USP, 10 mg in 1000-count bottles. The recall is due to the potential for some tablets not conforming to weight specifications. The record does not specify a remedy or what consumers should do with the product. Read more at govinfonow.com/recall/46723-teva-pharmaceuticals-usa-inc-recalls-propranolol-hydrochloride-tablets-usp-10.
Source Summary by GovInfoNow · govinfonow.com/recall/46723-teva-pharmaceuticals-usa-inc-recalls-propranolol-hydrochloride-tablets-usp-10 · Updated October 13, 2026 · FDA enforcement record: FDA #D-924-2013
Cite this page
“Teva Recalls Propranolol 10 mg Tablets Due to Weight Issues.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46723-teva-pharmaceuticals-usa-inc-recalls-propranolol-hydrochloride-tablets-usp-10. Based on FDA recall #D-924-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-924-2013%22&limit=1).
Why it’s dangerous
The hazard is that some tablets may not conform to weight specifications. The record does not explain the specific health risks or mechanism of injury associated with this deviation.
Who’s affected
Individuals who have purchased Propranolol Hydrochloride Tablets, USP, 10 mg in 1000-count bottles from nationwide distribution. The record does not specify which patients are most at risk.
How to tell if you have this one
Check if you have Propranolol Hydrochloride Tablets, USP, 10 mg in 1000-count bottles manufactured by Teva Czech Industries, sro. Look for NDC 50111-467-03 and lot numbers 6A301029 (Exp 1/2016) or 6A303025 (Exp 3/2016).
- Brand
Teva- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Teva recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-924-2013 (August 6, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-924-2013 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.